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Abstract
Introduction: Despite an early start, the provision of 
renal replacement therapy (RRT) in Sudan is constrained 
by economic factors. This report describes the ESRD 
population and the available renal replacement therapy 
(RRT) services in Sudan in 2009.
Current status: In June 2009, there were 2858 patients on 
hemodialysis (HD) in Sudan, 122 patients on continuous 
ambulatory peritoneal dialysis (CAPD), and 1168 kidney 
transplant recipients. The overall prevalence of treated 
ESRD was 106 patients per million population. All forms 
of RRT were funded by the government. The mean age 
of HD, CAPD and kidney transplant patients was 46±17, 
42±22 and 39±13 years respectively. Males constituted 
66%, 67.7% and 79.5% and children constituted 3.9%, 
25.3% and 6.6% of HD, CAPD and kidney transplant 
patients respectively. The commonest reported cause of 
kidney failure was hypertension (26.1%), followed by 
diabetes mellitus (DM) (10.4%), obstructive uropathy 
(7.6%), glomerulonephritis (GN) (5.5%), polycystic 
kidney disease (2.6%), and pyelonephritis (1.1%). The 
majority of HD patients (83.8%) are offered twice-
weekly HD, 83.6% had a functioning arterio-venous 
(AV)  fistula, 6.4% were positive for hepatitis B virus 
(HBV) infection, 6.5% were positive for hepatitis C 
virus (HCV) infection, and 0.7% were positive for both 
HBV and HCV. Target blood pressure, hemoglobin and 
phosphorus levels were achieved by 26.5%, 23.1% and 
28.5% of HD patients compared to 41.8%, 20.6% and 
63.5% of CAPD patients respectively. Kidney transplant 
recipients had their transplant operation performed in 
Sudan (33.1%), Egypt (20.7%), KSA (18.2%), Jordan 
(14.8%), Pakistan (8.4%) and other countries. 
Conclusion: The prevalence of RRT in Sudan remains 
low. Hypertension and diabetes mellitus are the most 
commonly reported cause of kidney failure.
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Introduction
End stage renal disease (ESRD) is a medical and social 
problem that constitutes a heavy burden on communities 
worldwide. Increasing global prevalence values of treated 
ESRD over the years indicate a general increase in the 
number of kidney failure patients as well as a gradual 
improvement in the access to the treatment. In 2007, 
more than 1,6 million  patients were undergoing dialysis 
treatment worldwide, and another half a million  patients 
were living with kidney transplantation [1]. 
The prevalence of treated ESRD patients in the general 
population shows a high global variation. In 2007, ESRD 
prevalence was around 2,300 per million population 
(p.m.p.) in Japan, around 1,700 p.m.p. in the USA, and 
about 925 p.m.p. in the European Union. The much 
lower global average of 325 p.m.p. suggests that access 
to treatment is still limited in many countries [1]. 
Intermittent peritoneal dialysis (IPD) was introduced in 
Sudan in 1968. In the same year, a personal set-up for 
home hemodialysis (HD) marked the start of HD in Sudan. 
The first renal unit was opened in Khartoum Teaching 
Hospital in 1970, where the first kidney transplant in 
Sudan and the second kidney transplant in the Middle 
East took place in 1974 [2]. 
Despite this early start, the provision of renal replacement 
therapy (RRT) in Sudan lagged behind many neighboring 
countries. The reasons behind that are mainly economical. 
The gross domestic product (GDP) per capita in Sudan 
was 2,086 US$ in 2007 [3], well below the 10,000 US$ 
limit that was noted by global surveys to imply economic 
restrictions on the prevalence of dialysis treatment [4]. 
Per capita total expenditure on health at average exchange 
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rate was 37 US$ in 2007 [5], barely enough to provide for 
essential health interventions [6].
The National Center for Kidney Diseases and Surgery 
was established in 1994 and the Sudan Program for 
Organ Transplantation was launched in 2000 resulting in 
a relative expansion of RRT in Sudan. In 2005, the Sudan 
Peritoneal Dialysis Program (Sudan-PD) was established 
and continuous ambulatory peritoneal dialysis (CAPD) 
became available for Sudanese ESRD patients. 
In this report, we will present a description of the ESRD 
population and RRT services in Sudan in the year 2009. 
We hope that it would provide a baseline estimate of 
various clinical performance indicators, guide continuous 
quality improvement schemes and help evaluate future 
progress.
Data collection methods
In June 2009, we conducted a cross sectional survey of 
all ESRD patients undergoing RRT in Sudan. Data of HD 
patients were collected simultaneously from all working 
HD centers by direct patient interviews, with a coverage 
rate of 93.3%. Data of CAPD patients were provided by 
Sudan-PD data base. Data of kidney transplant patients 
were collected by reviewing the pharmacy records and 
medical records of kidney transplant patients in the 
four national kidney transplant centers in Sudan, with a 
coverage rate of 73.4%.
Analysis of the demographic and clinical characteristics 
of the dialysis population was confined to patients who 
were maintained on the respective dialysis modality for 
90 days or more, referred to henceforth as prevalent HD 
or prevalent PD patients.
Prevalence of ESRD and RRT services
In June 2009, there were 2858 kidney failure patients 
undergoing HD in Sudan, 122 patients undergoing 
CAPD, and 1168 patients living with  functioning 
kidney allografts. In a population of 39 millions, these 
figures yield much lower prevalence rates than the global 
average in 2007 [1] (Figure 1). No kidney failure patient 
that reaches hospital is denied dialysis treatment. But it 
seems likely that large numbers of patients fail to present 
to hospital and are not diagnosed. 
Thus, kidney transplantation represent 28% of RRT 
in Sudan while HD and PD represent 69% and 3% 
respectively.
Age and gender of ESRD patients
Prevalent HD patients had a mean age of 46 years (SD 17, 
range 6-95 years). Prevalent CAPD patients had a mean 
age of 42 years (SD 22, range 1-81 years). Prevalent 
kidney transplant recipients (KTR) had a mean age of 39 
years (SD 13 years, range 6-80 years).
Males were commoner than females in all modalities, 
and children aged less than 18 years constituted a 
small percentage of patients (Figures 2, 3). This male 
predominance among the ESRD population is a poorly 
explained almost global phenomenon; with males 
Figure 1: Prevalence of different modalities of RRT in Sudan in 2009 compared with the global averages in 2007 [1]
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constituting 68% of the dialysis population in Egypt, 
56.1% in the USA ,  60% in UK, and 54.5% in KSA 
[7-10].
Causes of kidney failure
More than 40% of surveyed patients had no identified 
cause for their renal impairment. This is expected as most 
patients present with established kidney failure. The 
most probable causes of kidney failure in different RRT 
modalities are shown (Table 1). 
Hypertension was the most commonly reported cause of 
ESRD (26.1%), and this is likely to be an overestimation. 
The diagnosis of hypertensive nephrosclerosis is 
difficult to ascertain even in patients with long standing 
hypertension. Such patients may have had secondary 
hypertension due to undiagnosed kidney disease. 
Glomerulonephritis (GN) was the reported cause in a 
relatively small proportion of patients, and is probably 
the true underlying etiology in many of cases currently 
labeled as “uncertain etiology”. The diagnosis of GN 
is rarely confirmed by renal biopsy, and often relies on 
the presence of renal impairment, proteinuria or active 
urinary sediment in the absence of other causes. 
In an early description of 100 chronic renal failure patients 
presenting to Soba University Hospital in Sudan between 
1982 and 1984, GN was reported as responsible for 
38% of cases, followed by renal calculi (12%), diabetes 
mellitus (9%), chronic pyelonephritis (7%), sequelae of 
acute renal failure (5%), renal vascular disease (4%), 
polycystic kidney disease (3%), and obstructive uropathy 
not due to renal calculi (2%). In that series, the diagnosis 
of GN was made on the basis of small smooth kidneys 
seen radiologically in the intravenous urograms  with 
the absence of other etiologic factors, and histologic 
confirmation was obtained for only one third of patients. 
Only 20% of patients were labeled to have uncertain 
etiology and those were patients who reached the hospital 
very ill and died before investigations were completed 
[11].
In a previous report of 236 patients from two HD centers 
in Sudan, obstruction and polycystic kidney disease were 
reported as responsible for a similar percentage of cases 
(8.5% and 3% respectively), while a higher percentage 
was reported for GN (6.8%), a lower percentage for DM 
(5.9%) and a much lower percentage for hypertension 
(3.8%). In that series 71.2% of cases were labeled to have 
uncertain etiology [12].
This variation in the reported rates of hypertensive 
nephrosclerosis and GN probably results from different 
definitions of these conditions rather than a true variation 
in prevalence. A similarly wide variation is noted in 
the reported rates of hypertension as the primary renal 
diagnosis of ESRD patients in UK and USA (5.8% and 
24.3% respectively) [8, 9]. 
The findings of the current survey are consistent 
with reports from other African countries, in which 
hypertension seems to surpass DM as a cause of ESRD. 
Hypertension was the reported cause of kidney failure in 
21% of patients on RRT in the South African Registry, 
while the contribution of diabetic nephropathy was 
estimated to be 14-16% [13]. Hypertension accounted 
for 34.6% of ESRD in Black South African patients, 
compared to 4.3% in Whites, 13.8% in Indians, and 
20.9% in people of mixed ancestry [13].
In an early series of 115 black patients admitted to a 
chronic HD program in South Africa over a 4-year 
Figure 2: Gender distribution in different RRT modalities Figure 3: Percentage of children in different RRT modalities
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period, a definitive pathological diagnosis was made in 
70 cases. The cause of ESRD was malignant hypertension 
in 32 patients (45.7%), chronic GN in 26 patients (37%) 
and obstructive uropathy in 4 patients (5.7%). Patients 
diagnosed on clinical grounds only had a similar disease 
pattern [14].
Thus, the current estimates of the contribution of 
hypertension as the primary renal diagnosis in our ESRD 
population seem plausible. On the other hand, GN is 
likely to have been underestimated.
Approximately 19% of surveyed ESRD patients had a 
first or second degree relative with renal impairment. In 
a similar survey that included 4365 HD patients in two 
states in USA, 20% of patients reported having a first 
or second degree relative with ESRD [15]. This suggests 
that close relatives of ESRD patients may benefit from 
directed screening and preventive efforts.
Hemodialysis
In 1995, there were two HD centers in Sudan with six 
working machines, all of them in the capital Khartoum, 
dialyzing 56 patients per week [2].
In June 2009, there were 41 working HD centers in 
Sudan: 25 governmental centers serving 1789 patients 
and 16 private centers serving 1069 patients. Thus, 
governmental and private HD centers served 62.6% and 
37.4% of the HD population respectively.
HD services in Sudan are funded by the government, 
including services provided by private centers. Patients 
do not pay for their HD sessions. The majority of HD 
patients (83.8%) in Sudan are offered twice-weekly HD 
for economical reasons. According to the NKF/KDOQI 
guidelines twice-weekly HD is not appropriate for 
patients without significant residual renal function [16]. 
The total number of kidney failure patients undergoing 
HD was 2858 patients; 2374 (83.1%) were ESRD 
patients that had been maintained on HD for 3 months 
or more, 265 (9.3%) were ESRD patients that had been 
maintained on HD for less than 3 months, 28 (1%) were 
ARF patients, and 191 (6.7%) were patients for whom 
we had no data on dialysis duration. 
Only 37.7% of prevalent HD patients were diagnosed to 
have CKD at least 3 months before dialysis initiation. The 
majority of patients had a functioning AV fistula (83.6%), 
while 7.3% had a tunneled HD catheter and 9.1% had 
a non-tunneled catheter. Non-tunneled catheters were 
most commonly placed in the jugular vein (80.9%), 
18% were placed in the femoral vein and 1.1% in the 
subclavian vein. This complies with the NKF/KDOQI 
vascular access guidelines which recommend that greater 
than 65% of prevalent HD patients have a functional AV 
fistula [16]. 
The prevalence of HBV infection was 6.4%, the 
prevalence of HCV infection was 6.5%, and 0.7% had 
combined HBV and HCV infection. Two earlier reports 
estimated the prevalence of HCV infection among a 
group of HD patients in Sudan to be 23.7% and 34.9% 
[12, 17]. However, both reports referred to one or two 
HD centers and do not reflect the general situation. 
Due to practical constrains, adequacy measures have 
little practical value in our setting. Only 17% of prevalent 
HD patients had a documented measurement of the urea 
reduction ratio (URR), and only 47% achieved a URR ≥ 
65%.
The target pre-dialysis blood pressure (BP) of <140/90 
mmHg and the target post-dialysis BP of <130/80 
mmHg were achieved in only 26.5% of patients. Only 
23.1% of patients achieved the target hemoglobin of ≥ 
11 g/dl. Parenteral iron was used by 69% of patients and 
Table 1: Causes of kidney failure in different RRT modalities
Cause of renal failure (%) HD PD KTR ESRD
Uncertain etiology 40.1 32.4 50.8 42.6
Hypertension 27.3 33.8 22 26.1
Diabetes Mellitus 12 14.9 5 10.4
Obstructive uropathy 8.9 4.1 4 7.6
Glomerulonephritis 3.9 6.8 10 5.5
Polycystic kidney disease 2.8 1.4 2 2.6
Pyelonephritis 1.3 0 1 1.1
Others 3.8 6.8 5 4.1
HD: hemodialysis; PD: peritoneal dialysis; KTR: kidney transplant recipient; ESRD: end stage renal disease
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erythropoietin in any dose was used by 79%. Only 28.5% 
of patients achieved phosphorus level ≤ 5.5 mg/dl.
Only 19.7% of prevalent HD patients were being 
evaluated/prepared for kidney transplantation. The most 
commonly cited reason for not being evaluated for kidney 
transplantation was lack of a suitable live kidney donor 
(Table 1). 
Peritoneal dialysis
In 1995, there were 15 hospital beds dedicated for PD, all 
of them in Khartoum, and about 70 ESRD patients were 
maintained on IPD [2].
There were 122 patients on CAPD in Sudan in June 
2009. Cycler PD is not available yet in Sudan and IPD 
is only used as a temporary measure. CAPD patients 
are followed up in eight PD centers. Dialysis fluids are 
provided for patients free of charge
Among CAPD patients, 99 patients (81.1%) had been on 
PD for 3 months or more and 23 patients (18.9%) had 
been on PD for less than 3 months. The commonest cause 
for choosing CAPD was patient preference (56%); other 
reasons were vascular access problems (26%), being 
medically unfit for HD (8%), being a child less than 
5 years old (6%), and the lack of HD facility near the 
patient's living place (4%).
Only 45.3% of prevalent patients had a documented Kt/V 
measurement over the previous six months, and 71.8% 
achieved the target Kt/V ≥ 1.7. Target BP ≤ 130/80 
mmHg was achieved by 41.8% of prevalent patients. 
Target hemoglobin ≥ 11 g/dl was achieved by 20.6% of 
prevalent patients. Target phosphorus level ≤ 5.5 mg/dl 
was achieved by 63.5% of prevalent patients.
Kidney transplantation
Until 1995, a total of 30 transplants have been performed 
in Sudan, and there were about 200 kidney transplant 
recipients in the country. The majority had their operation 
done in Saudi Arabia (KSA), the rest were done in Egypt, 
Kuwait, Jordan, India and European countries [2].
The number of ESRD patients with a functioning kidney 
allograft in June 2009 was 1168 patient. Transplant 
operations performed within the country are funded 
by the government, as well as the cost of maintenance 
immunosuppressive medications for all patients. The 
proportion of kidney transplants performed inside Sudan 
was only 33.1%.  Transplants performed outside the 
country most commonly took place in Egypt (20.7%), 
KSA (18.2%), Jordan (14.8%) and Pakistan (8.4%). All 
grafts were obtained from live donors, and the majority 
were from live related donor (Table 3)
Patients were  generally maintained on triple immuno-
suppression; 54.9% were maintained on cyclosporine, 
while 45.1% were maintained on tacrolimus. Target BP ≤ 
130/80 mmHg was achieved only by 32.9% of patients, 
and target hemoglobin ≥ 11 g/dl was achieved by 81.5% 
of patients. 
Conclusion
Access to RRT in Sudan has improved over the last 
two decades, but remains very low. This improvement 
is mostly due to the government commitment to the 
treatment of ESRD patients. Hypertension and DM are 
the most commonly reported causes of kidney failure. 
One third of patients live with  functioning kidney grafts, 
and the vast majority of the remainder are maintained on 
HD.
Table 2: Reasons cited by prevalent HD patients for not 
being evaluated/prepared for kidney transplantation
Reason Number %
Patient has no suitable kidney donor 709 42.4
Patient prefers to stay on dialysis 250 15
Patient is still considering the matter 214 12.8
Patient has a medical contra-indication 212 12.7
Financial constrains 110 6.6
Patient not counseled about transplant 81 4.8
Other reasons 95 5.7
Total 1672 100
Table 3: Relation of kidney donor to patients living with a 
functioning kidney graft in Sudan
Kidney donor relation Number %
Brother or sister 395 33.8
Son or daughter 129 11.0
Other related 96 8.2
Mother or father 39 3.3
Live unrelated 174 14.9
No data 335 28.7
Total 1168 100
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